Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Zhe Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5796-4335; OpenAlex author ID A5100462336. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers

Papers 4

  1. Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer. Last author DOI 10.1016/j.cytogfr.2023.07.006↗
  2. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Co-author DOI 10.1186/s12943-022-01696-5↗
  3. Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Last author DOI 10.1038/s41419-021-03938-8↗
  4. siRNA-Mediated SBF2 Silencing May Inhibit Pancreatic Cancer Cells via Attenuation of the TGF-β Signaling Pathway. First author DOI 10.1177/1533034615580724↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Ma · 2 shared papers, 2021–2023 · strength 0.34
  2. Jin Long · 2 shared papers, 2016–2023 · strength 0.27
  3. Yuanhong Xu · 2 shared papers, 2016–2021 · strength 0.22
  4. Wei Guo · 1 shared paper, 2023 · strength 0.19
  5. Prashant Kesharwani · 1 shared paper, 2023 · strength 0.18
  6. Kejian Guo · 1 shared paper, 2021 · strength 0.15
  7. Shaowei Song · 1 shared paper, 2021 · strength 0.15
  8. Xingda Wu · 1 shared paper, 2016 · strength 0.08
  9. Chunlin Ge · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.